AB, M., G, I., N, M., N, A., DM, P., J, M., . . . M, D. (2025). Endothelial dysfunction and hemostatic imbalance in CAR T-cell-associated toxicities: Pathophysiological insights and the role of circulating biomarkers. Frontiers in immunology, 16, 1699894. https://doi.org/10.3389/fimmu.2025.1699894
Chicago Style (17th ed.) CitationAB, Moreno-Castaño, Iraola G, Martínez-Cibrián N, Albiol N, Prats DM, Martinez-Sanchez J, Castro P, and Diaz-Ricart M. "Endothelial Dysfunction and Hemostatic Imbalance in CAR T-cell-associated Toxicities: Pathophysiological Insights and the Role of Circulating Biomarkers." Frontiers in Immunology 16 (2025): 1699894. https://doi.org/10.3389/fimmu.2025.1699894.
MLA (9th ed.) CitationAB, Moreno-Castaño, et al. "Endothelial Dysfunction and Hemostatic Imbalance in CAR T-cell-associated Toxicities: Pathophysiological Insights and the Role of Circulating Biomarkers." Frontiers in Immunology, vol. 16, 2025, p. 1699894, https://doi.org/10.3389/fimmu.2025.1699894.